Morning, Wednesday, 6th February 2019
THIS EVENT IS CPD CERTIFIED
This seminar will provide a timely opportunity to assess progress made so far in slowing the development of antimicrobial resistance (AMR) as Government and stakeholders consider key priorities for the new AMR strategy.
In light of the Health and Social Care Select Committee inquiry into the Government’s response to the challenge of AMR - and completion of the UK 5 year Antimicrobial Resistance Strategy 2013 to 2018 - delegates will consider the threat posed to public health by AMR and the challenges for implementing the next 5 year strategy.
Following the recent publication of the UK’s biological security strategy, attendees will also discuss the next steps for strengthening international collaboration on AMR, which is highlighted as a key strand of the strategy.
Sessions will examine the factors contributing towards resistance and the measures being taken by industry and healthcare professionals to encourage the responsible use of antibiotics, including attention to reimbursement models and how these might be altered to discourage the prescription and use of antibiotics.
Further sessions will also assess future research priorities, in light of the £10m Small Business Research Initiative and £30m funding to tackle AMR recently made available by the Government.